SunOpta (NASDAQ:STKL – Get Free Report) (TSE:SOY) had its price objective hoisted by Stephens from $9.00 to $10.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Stephens’ price target would suggest a potential upside of 38.50% from the stock’s previous close.
A number of other brokerages have also recently commented on STKL. StockNews.com cut SunOpta from a “hold” rating to a “sell” rating in a research note on Friday, November 1st. DA Davidson reaffirmed a “buy” rating and issued a $9.00 target price on shares of SunOpta in a research note on Thursday, October 10th. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $9.50.
View Our Latest Analysis on SunOpta
SunOpta Trading Up 6.5 %
SunOpta (NASDAQ:STKL – Get Free Report) (TSE:SOY) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.01. SunOpta had a positive return on equity of 6.51% and a negative net margin of 23.23%. The business had revenue of $171.00 million during the quarter, compared to the consensus estimate of $159.95 million. During the same quarter in the prior year, the company posted ($0.03) earnings per share. The firm’s revenue was down 17.7% on a year-over-year basis. As a group, analysts predict that SunOpta will post 0.14 earnings per share for the current year.
Institutional Investors Weigh In On SunOpta
Large investors have recently bought and sold shares of the company. First Bank & Trust increased its position in shares of SunOpta by 7.9% during the third quarter. First Bank & Trust now owns 25,409 shares of the company’s stock worth $162,000 after acquiring an additional 1,856 shares in the last quarter. Mackenzie Financial Corp increased its position in shares of SunOpta by 0.9% during the second quarter. Mackenzie Financial Corp now owns 254,678 shares of the company’s stock worth $1,370,000 after acquiring an additional 2,155 shares in the last quarter. Creative Planning increased its position in shares of SunOpta by 9.3% during the third quarter. Creative Planning now owns 30,716 shares of the company’s stock worth $196,000 after acquiring an additional 2,617 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of SunOpta by 13.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 26,913 shares of the company’s stock worth $185,000 after acquiring an additional 3,171 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its position in shares of SunOpta by 10.5% during the second quarter. The Manufacturers Life Insurance Company now owns 36,958 shares of the company’s stock worth $200,000 after acquiring an additional 3,521 shares in the last quarter. Institutional investors own 85.39% of the company’s stock.
SunOpta Company Profile
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Featured Stories
- Five stocks we like better than SunOpta
- What is the Nikkei 225 index?
- What a Trump Win Looks Like for the Market Now and Into 2025
- What is a Special Dividend?
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- How to Calculate Return on Investment (ROI)
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for SunOpta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta and related companies with MarketBeat.com's FREE daily email newsletter.